DIAPH1 and hepatocellular carcinoma: And the relationship between Rho GTPase family and tumor was also intricate, recent study revealed one of Rho-family effectors MDIA1 could influence the nanomechanical signature of liver cancer and further modulated the biological behavior of HCC [26].